87 related articles for article (PubMed ID: 3140086)
1. Oral treatment of peritonitis in CAPD patients with ofloxacin.
Chan MK; Chau PY; Chan WW
Nephrol Dial Transplant; 1988; 3(2):194-7. PubMed ID: 3140086
[TBL] [Abstract][Full Text] [Related]
2. Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin.
Chan MK; Chau PY; Chan WW
J Antimicrob Chemother; 1988 Sep; 22(3):371-5. PubMed ID: 3182430
[TBL] [Abstract][Full Text] [Related]
3. Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients?
Gucek A; Bren AF; Lindic J; Hergouth V; Mlinsek D
Adv Perit Dial; 1994; 10():144-6. PubMed ID: 7999813
[TBL] [Abstract][Full Text] [Related]
4. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
[TBL] [Abstract][Full Text] [Related]
5. Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
Chan MK; Chau PY; Chan WW
Clin Nephrol; 1987 Dec; 28(6):277-80. PubMed ID: 3481692
[TBL] [Abstract][Full Text] [Related]
6. [Transperitoneal resorption of cefotiam in CAPD patients with and without peritonitis].
Thomae U; Koblinger S
Med Klin (Munich); 1994 Sep; 89(9):464-8. PubMed ID: 7968880
[TBL] [Abstract][Full Text] [Related]
7. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
8. The case for oral treatment of peritonitis in continuous ambulatory peritoneal dialysis.
Passadakis P; Oreopoulos D
Adv Perit Dial; 2001; 17():180-90. PubMed ID: 11510271
[TBL] [Abstract][Full Text] [Related]
9. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
Møller JK; Hagelskjaer LH
Ugeskr Laeger; 1996 Apr; 158(18):2538-41. PubMed ID: 8686007
[TBL] [Abstract][Full Text] [Related]
10. A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Chan MK; Cheng IK; Ng WS
Am J Kidney Dis; 1990 Feb; 15(2):155-9. PubMed ID: 2405653
[TBL] [Abstract][Full Text] [Related]
11. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
12. Oral pefloxacin in the treatment of CAPD peritonitis.
Tan HW; Kon SP; Chua CT; Ngeow NF
Med J Malaysia; 1992 Jun; 47(2):128-33. PubMed ID: 1494333
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S
Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394
[TBL] [Abstract][Full Text] [Related]
15. [Our protocol in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis].
Kostić S; Ljuvenović S; Velicković R; Stefanović V; Raicević R; Cukuranović R; Veljković S; Djordjević V; Malobabić Z
Srp Arh Celok Lek; 1996; 124 Suppl 1():149-51. PubMed ID: 9102884
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks].
Bulut C; Oztürk R; Yilmaz GR; Parpucu H; Irmak H; Kinikli S; Duranay M; Demiröz AP
Mikrobiyol Bul; 2008 Apr; 42(2):255-64. PubMed ID: 18697423
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
[TBL] [Abstract][Full Text] [Related]
18. [Peritonitis in continuous ambulatory peritoneal dialysis. An evaluation of the empiric initial antibiotic treatment].
Hagelskjaer LH; Møller JK
Ugeskr Laeger; 1996 Apr; 158(18):2532-7. PubMed ID: 8686006
[TBL] [Abstract][Full Text] [Related]
19. Single- and multiple-dose kinetics of ofloxacin in patients on continuous ambulatory peritoneal dialysis (CAPD).
Passlick J; Wonner R; Keller E; Essers L; Grabensee B
Perit Dial Int; 1989; 9(4):267-72. PubMed ID: 2488379
[TBL] [Abstract][Full Text] [Related]
20. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients.
Chuang YW; Shu KH; Yu TM; Cheng CH; Chen CH
Nephrol Dial Transplant; 2009 May; 24(5):1603-8. PubMed ID: 19103738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
